Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
Open Access
- 8 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-10
Abstract
Our aim was to determine the epidemiology and recent changes in the trends of non-functional pancreatic neuroendocrine tumours (NF-pNETs) at the population level. In addition, we explored the risk factors that are associated with survival duration. Cases were identified form the Surveillance, Epidemiology, and End Results (SEER) Programme database from 2000 to 2014. Data on incidence and incidence-based (IB) mortality for NF-pNET were obtained from this database. Secular trends in age-adjusted incidence and IB mortality were determined by using the Joinpoint Regression program. Data analyses were performed using chi-square tests, Kaplan-Meier curves and Cox proportional hazards regression. Overall, 4766 patients diagnosed with NF-pNET with a median age of 59 years were identified through our descriptive criteria. Caucasian patients accounted for the majority of the study population, and the proportion of patients with distant disease significantly decreased during our study period. Overall, there was an increase in incidence and IB mortality for NF-pNET; however, the rate of increase decreased during the recent years. In addition, the incidence trends of NF-pNET located in the pancreatic head significantly increased, and rates fo increase in IB mortality for NF-pNET in the pancreatic tail decreased in recent years. Additionally, the 1-, 5-, and 10-year survival rates were 79.0, 51.8, 38.1%, respectively. Furthermore, patient age, tumour grade, stage at diagnosis, tumour size, tumour site and resection were associated with mortality. Despite increases in incidence and IB mortality, the rate of change in IB mortality for NF-pNET has decreased in recent years. Survival duration displayed a secular increase during the overall period, and the prognosis and survival duration of patients were closely related to the time of diagnosis, age of the patients and size and location of the tumour. Appropriate treatment adjustments based on tumour stage may thus facilitate improvements in patient outcomes.Keywords
Funding Information
- Youth Science Foundation of Jiangxi Province (20171BAB215037)
- Key research and development program funding in Jiangxi province (20181BBG70010)
This publication has 30 references indexed in Scilit:
- Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective studyJapanese Journal of Clinical Oncology, 2015
- A Rare Case of Calf Muscle Metastasis from a Non-Functional Pancreatic Neuroendocrine CarcinomaIranian Journal of Radiology, 2015
- Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and managementWorld Journal of Gastroenterology, 2015
- Nonfunctional Pancreatic Neuroendocrine TumorsSurgical Clinics of North America, 2014
- Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesJournal of Gastroenterology, 2012
- Pancreatic neuroendocrine tumorsCancer, 2009
- Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine TumorsAnnals of Surgery, 2008
- Population-Based Study of Islet Cell CarcinomaAnnals of Surgical Oncology, 2007
- Pancreatic endocrine tumorsJournal of Surgical Research, 2004
- Synaptophysin: a marker protein for neuroendocrine cells and neoplasms.Proceedings of the National Academy of Sciences, 1986